MARKET

LEXX

LEXX

Lexaria Bioscience Corp
NASDAQ
0.7001
+0.0185
+2.71%
Opening 09:30 12/18 EST
OPEN
0.6990
PREV CLOSE
0.6816
HIGH
0.7001
LOW
0.6990
VOLUME
16.09K
TURNOVER
--
52 WEEK HIGH
2.430
52 WEEK LOW
0.6767
MARKET CAP
15.56M
P/E (TTM)
-1.0587
1D
5D
1M
3M
1Y
5Y
1D
Lexaria Bioscience Issues Warrants to Purchase 2.66 Million Shares
Reuters · 1d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 2d ago
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
TipRanks · 2d ago
Lexaria Bioscience plummets on $3.5M equity offering
Seeking Alpha · 3d ago
UPDATE: Lexaria Bioscience Announces $3.5M Registered Direct Offering Of 2,661,600 Shares At A Price Of $1.315/Share
Benzinga · 3d ago
Lexaria Bioscience prices 2.66M share at the market offering at $1.315
TipRanks · 3d ago
Weekly Report: what happened at LEXX last week (1208-1212)?
Weekly Report · 3d ago
More
About LEXX
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.

Webull offers Lexaria Bioscience Corp stock information, including NASDAQ: LEXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXX stock methods without spending real money on the virtual paper trading platform.